Sumitomo Pharma (DNPUF) News Today $4.50 -0.50 (-10.00%) As of 03/11/2025 10:38 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Jefferies lifts Sumitomo Pharma stock rating to Buy, targets JPY900February 3, 2025 | msn.comSumitomo Pharma and Janssen Collaborate on Schizophrenia Medications in JapanJanuary 20, 2025 | tipranks.comSumitomo Dainippon Pharma Reports Improved FinancialsNovember 1, 2024 | markets.businessinsider.comSumitomo Pharma Streamlines Workforce with Retirement ProgramOctober 30, 2024 | markets.businessinsider.comSumitomo Pharma Reports Significant Forex LossesOctober 30, 2024 | markets.businessinsider.comNWPHF Newron Pharmaceuticals S.p.A.October 17, 2024 | seekingalpha.comSumitomo Pharma Co. Ltd.October 8, 2024 | wsj.comJapan's Sumitomo Corp enters renewable energy market in IndiaSeptember 14, 2024 | reuters.comJapanese pharma stocks surge to record highs after market routAugust 26, 2024 | finance.yahoo.comSumitomo Dainippon Pharma earnings: here's what Wall Street expectsJuly 30, 2024 | markets.businessinsider.comSMDPY Sumitomo Pharma Co., Ltd.May 22, 2024 | seekingalpha.comSumitomo Dainippon Pharma is about to announce its earnings — here's what to expectMay 14, 2024 | markets.businessinsider.comSumitomo Corporation: Still Neutral After Reviewing Results And Financial TargetsMay 9, 2024 | seekingalpha.comJapan's Sumitomo Corp net profit down 32% on Madagascar one-off lossMay 2, 2024 | msn.comJapan's Sumitomo plans $1.3 billion renewable power storage network, Nikkei reportsApril 23, 2024 | reuters.comSeaTwirl partners Sumitomo to promote vertical-axis wind turbines in JapanApril 3, 2024 | msn.comSumitomo subsidiary Sunstate acquires TSRMarch 29, 2024 | msn.comJapanese pharma with North Carolina offices to lay off 400March 6, 2024 | bizjournals.comSumitomo Pharma Cuts 400 US Jobs as Credit Market Concerns MountMarch 5, 2024 | bloomberg.comSumitomo Dainippon Pharma Co Ltd (4506)January 30, 2024 | uk.investing.comSumitomo Pharma Co Ltd 4506December 19, 2023 | morningstar.comSumitomo Pharma America and Actress Holly Robinson Peete Extend Time To Go™ Campaign to Empower People with Overactive BladderNovember 21, 2023 | markets.businessinsider.comHealth Canada approves Sumitomo’s prostate cancer treatmentOctober 24, 2023 | msn.comSignal: Sumitomo invests in Nano One Materials CorpOctober 2, 2023 | msn.comSalipro Biotech enters into research collaboration with Sumitomo Pharma to advance a drug discovery programSeptember 12, 2023 | technews.tmcnet.comHere's what Wall Street expects from Sumitomo Dainippon Pharma's earningsJuly 30, 2023 | markets.businessinsider.comGinkgo Bioworks and Sumitomo Chemical Announce Expanded Partnership To Develop Functional Chemicals with Synthetic BiologyJuly 18, 2023 | technews.tmcnet.comSumitomo Metal IndustriesJune 24, 2023 | forbes.comSumitomo Dainippon Pharma (TYO:4506) Price Target Decreased by 10.51% to 868.46June 1, 2023 | msn.com3 Pharma Stocks That Will Boom Thanks to AIMay 26, 2023 | markets.businessinsider.comSunovion, Sumitomo To Lay Off 223 At Marlborough OfficesMay 2, 2023 | msn.comSumitomo Pharma Subsidiary Companies in the U.S., Including Sunovion, to Combine and Form Sumitomo Pharma AmericaApril 3, 2023 | benzinga.comSumitomo Pharma Subsidiary Companies in the U.S., Including Sumitomo Pharma Oncology, to Combine and Form Sumitomo Pharma AmericaApril 3, 2023 | markets.businessinsider.comNippon Paper, others look at making sustainable aviation fuel from woodFebruary 3, 2023 | reuters.comJapan’s Sumitomo Mitsui Boosts Stake In Philippines’ RCBC With $460 Million InvestmentNovember 3, 2022 | forbes.comSumitomo Pharma Co., Ltd. (DNPUF)October 20, 2022 | finance.yahoo.comRevisiting Myovant... October 4, 2022 | markets.businessinsider.comSumitomo Offers to Buy All of Myovant in Deal Worth $2.5 BillionOctober 3, 2022 | bloomberg.comSumitomo Pharma Co LtdSeptember 10, 2022 | reuters.comJapan's Sumitomo Mitsui reports Q1 profit jump, Mizuho suffers dropJuly 30, 2022 | reuters.comHere's what Wall Street expects from Sumitomo Dainippon Pharma's earnings reportJuly 28, 2022 | markets.businessinsider.comJazz Pharmaceuticals and Sumitomo Pharma Announce Exclusive License Agreement to Develop and Commercialize DSP-0187, a Potent, Highly Selective Oral Orexin-2 Receptor AgonistMay 4, 2022 | finance.yahoo.comSumitomo Dainippon Pharma Oncology Appoints Jatin J. Shah, M.D. as Chief Medical OfficerFebruary 22, 2022 | yahoo.comSumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1 Dose Expansion Study of TP-1287 in Patients with SarcomaNovember 3, 2021 | prnewswire.comSumitomo Dainippon Pharma is about to announce its earnings — here's what Wall Street expectsOctober 28, 2021 | markets.businessinsider.comSumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1 Study of DSP-0390 in Patients with Recurrent High-Grade GliomaOctober 21, 2021 | prnewswire.comSumitomo Dainippon Pharma Co. Ltd (DNPUF)August 5, 2021 | nasdaq.comHere's what to expect from Sumitomo Dainippon Pharma's earnings reportJuly 27, 2021 | markets.businessinsider.com Remove Ads Get Sumitomo Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for DNPUF and its competitors with MarketBeat's FREE daily newsletter. Email Address DNPUF Media Mentions By Week DNPUF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DNPUF News Sentiment▼0.000.80▲Average Medical News Sentiment DNPUF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DNPUF Articles This Week▼00▲DNPUF Articles Average Week Remove Ads Get Sumitomo Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for DNPUF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 1933 Industries News Today 4Front Ventures News Today AB Science News Today Acreage News Today Almirall News Today Amazonas Florestal News Today American Green News Today Avant Brands News Today Avicanna News Today BioGaia AB (publ) News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:DNPUF) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersTrump announces revenge on BidenA former CIA insider just made a stunning prediction: Trump’s revenge on Biden will end America’s energy cr...Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'Trump Orders ‘National Digital Asset Stockpile’ THIS could be the coin they choose…Crypto 101 Media | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredWarning: What they're not telling you about these recent selloffsIn light of massive recent selloffs... our senior analyst Dan Ferris has issued a new warning for the American...Stansberry Research | SponsoredSilent Raid on IRAs and 401(k)s Begins—Are You Next?Look around—everything feels oddly steady. Gas prices aren't skyrocketing. Banks aren't collapsing. The mar...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sumitomo Pharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sumitomo Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
